List of alzheimer's disease patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7563808 Methods for treating cognitive impairments or dementia	Patent 7563808 was granted and assigned to Eisai on July, 2009 by the United States Patent and Trademark Office.		Eisai	United States Patent and Trademark Office	7563808	July 21, 2009
‌ US Patent 7582631 Substituted heterocyclic compounds and methods of use	Patent 7582631 was granted and assigned to Amgen on September, 2009 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7582631	September 1, 2009
‌ US Patent 9517264 Human FGF receptor and β-Klotho binding proteins	Patent 9517264 was granted and assigned to Amgen on December, 2016 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	9517264	December 13, 2016
‌ US Patent 11786508 Use of sublingual dexmedetomidine for the treatment of agitation	Patent 11786508 was granted and assigned to Bioxcel Therapeutics Inc. on October, 2023 by the United States Patent and Trademark Office.	Bioxcel Therapeutics Inc.	Bioxcel Therapeutics Inc.	United States Patent and Trademark Office	11786508	October 17, 2023
‌ US Patent 11607451 Self-buffering antibody formulations	Patent 11607451 was granted and assigned to Amgen on March, 2023 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11607451	March 21, 2023
‌ US Patent 7833979 Toxin peptide therapeutic agents	Patent 7833979 was granted and assigned to Amgen on November, 2010 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7833979	November 16, 2010
‌ US Patent 11839604 Use of sublingual dexmedetomidine for the treatment of agitation	Patent 11839604 was granted and assigned to Bioxcel Therapeutics Inc. on December, 2023 by the United States Patent and Trademark Office.	Bioxcel Therapeutics Inc.	Bioxcel Therapeutics Inc.	United States Patent and Trademark Office	11839604	December 12, 2023
‌ US Patent 10569014 Device and method for making aseptic connections	Patent 10569014 was granted and assigned to Amgen on February, 2020 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10569014	February 25, 2020
‌ US Patent 9061097 Drug delivery device	Patent 9061097 was granted and assigned to Amgen on June, 2015 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	9061097	June 23, 2015
‌ US Patent 10492990 Drug cassette, autoinjector, and autoinjector system	Patent 10492990 was granted and assigned to Amgen on December, 2019 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10492990	December 3, 2019
‌ US Patent 6951865 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same	Patent 6951865 was granted and assigned to Eisai on October, 2005 by the United States Patent and Trademark Office.		Eisai	United States Patent and Trademark Office	6951865	October 4, 2005
‌ US Patent 11020537 Drug cassette, autoinjector, and autoinjector system	Patent 11020537 was granted and assigned to Amgen on June, 2021 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11020537	June 1, 2021
‌ US Patent 7919498 Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors	Patent 7919498 was granted and assigned to Amgen on April, 2011 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7919498	April 5, 2011
‌ US Patent 11878149 Drug delivery device	Patent 11878149 was granted and assigned to Amgen on January, 2024 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11878149	January 23, 2024
‌ US Patent 11445955 Method and system for correlating an image capturing device to a human user for analysis of cognitive performance		Neurotrack	Neurotrack	United States Patent and Trademark Office	11445955	September 20, 2022
‌ US Patent 11423256 Biological image transformation using machine-learning models	Patent 11423256 was granted and assigned to Insitro on August, 2022 by the United States Patent and Trademark Office.	Insitro	Insitro	United States Patent and Trademark Office	11423256	August 23, 2022
‌ US Patent 7442778 Modified Fc molecules	Patent 7442778 was granted and assigned to Amgen on October, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7442778	October 28, 2008
‌ US Patent 11142529 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 11142529 was granted and assigned to AgeneBio on October, 2021 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio	United States Patent and Trademark Office	11142529	October 12, 2021
‌ US Patent 11998528 Non-sedating dexmedetomidine treatment regimens	Patent 11998528 was granted and assigned to Bioxcel Therapeutics Inc. on June, 2024 by the United States Patent and Trademark Office.	Bioxcel Therapeutics Inc.	Bioxcel Therapeutics Inc.	United States Patent and Trademark Office	11998528	June 4, 2024
‌ US Patent 11890272 Non-sedating dexmedetomidine treatment regimens	Patent 11890272 was granted and assigned to Bioxcel Therapeutics Inc. on February, 2024 by the United States Patent and Trademark Office.	Bioxcel Therapeutics Inc.	Bioxcel Therapeutics Inc.	United States Patent and Trademark Office	11890272	February 6, 2024
‌ US Patent 11351308 Auto-injector with signaling cap		Amgen	Amgen	United States Patent and Trademark Office	11351308	June 7, 2022
‌ US Patent 10092703 Drug cassette, autoinjector, and autoinjector system	Patent 10092703 was granted and assigned to Amgen on October, 2018 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	10092703	October 9, 2018
‌ US Patent 10329301 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 10329301 was granted and assigned to AgeneBio on June, 2019 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio	United States Patent and Trademark Office	10329301	June 25, 2019
‌ US Patent 7429608 Benzo[	Patent 7429608 was granted and assigned to Amgen on September, 2008 by the United States Patent and Trademark Office.		Amgen	United States Patent and Trademark Office	7429608	September 30, 2008
‌ US Patent 11266777 Drug delivery device, method of manufacture, and method of use	Patent 11266777 was granted and assigned to Amgen on March, 2022 by the United States Patent and Trademark Office.	Amgen	Amgen	United States Patent and Trademark Office	11266777	March 8, 2022

...

Results per page:

2,483 results

0 selected

2,483 results

0 selected